Nova Patents
BRPI0618552B8

Oxygen linked pyrimidine derivatives

Abstract

oxygen-linked pyrimidine derivatives. The present invention relates to pyrimidine compounds which are useful as antiproliferative agents. more particularly, the present invention relates to oxygen-linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds, and uses of these compounds in the treatment of proliferative disorders. these compounds may be useful as medicines for the treatment of a variety of proliferative disorders, including tumors and cancers, as well as other disorders or conditions related to or associated with the kinases.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

77 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
73683805United States of AmericaP
81733906United States of AmericaP
85128306United States of AmericaP
2006000352SingaporeW
60736838
60817339
60851283
PCTSG2006000352
US20050736838P
US20060817339P
US20060851283P
WO2006SG00352

Members77

Family members, oldest first
DocumentOfficeKind
AU2006316071A1AustraliaA1
AU2006316072A1AustraliaA1
CA2629443A1CanadaA1
CA2629455A1CanadaA1
WO2007058627A1World Intellectual Property Organization (WIPO)A1
WO2007058628A1World Intellectual Property Organization (WIPO)A1
TW200736262ATaiwan Province of ChinaA
TW200738735ATaiwan Province of ChinaA
EP1951729A1European Patent Office (EPO)A1
EP1951730A1European Patent Office (EPO)A1
KR20080086443ARepublic of KoreaA
KR20080090390ARepublic of KoreaA
CN101360751AChinaA
CN101365703AChinaA
US2009075999A1United States of AmericaA1
JP2009515954AJapanA
JP2009517344AJapanA
HK1123282A1Hong Kong, ChinaA1
HK1124040A1Hong Kong, ChinaA1
EP1951729A4European Patent Office (EPO)A4
EP1951730A4European Patent Office (EPO)A4
ZA200804208BSouth AfricaB
US2009258886A1United States of AmericaA1
EP1951730B1European Patent Office (EPO)B1
AT469158TAustriaT
ATE469158T1AustriaT1
DE602006014579D1GermanyD1
PT1951730EPortugalE
DK1951730T3DenmarkT3
ES2346791T3SpainT3
PL1951730T3PolandT3
SI1951730T1SloveniaT1
AU2006316071B2AustraliaB2
NZ568325ANew ZealandA
BRPI0618552A2BrazilA2
CN101360751BChinaB
AU2006316072B2AustraliaB2
US8143255B2United States of AmericaB2
US8153632B2United States of AmericaB2
US2012142680A1United States of AmericaA1
US2012196855A1United States of AmericaA1
MY148072AMalaysiaA
US8415338B2United States of AmericaB2
JP5225856B2JapanB2
US2013172338A1United States of AmericaA1
TWI407961BTaiwan Province of ChinaB
CN101365703BChinaB
JP5380073B2JapanB2
KR20140037256ARepublic of KoreaA
KR20140037257ARepublic of KoreaA
TW201418263ATaiwan Province of ChinaA
EP1951729B1European Patent Office (EPO)B1
PT1951729EPortugalE
DK1951729T3DenmarkT3
KR20140117679ARepublic of KoreaA
ES2506040T3SpainT3
SI1951729T1SloveniaT1
PL1951729T3PolandT3
KR101499594B1Republic of KoreaB1
KR101513492B1Republic of KoreaB1
US9133214B2United States of AmericaB2
TWI506029BTaiwan Province of ChinaB
KR101568801B1Republic of KoreaB1
CY1112245T1CyprusT1
KR101576159B1Republic of KoreaB1
TWI525096BTaiwan Province of ChinaB
CA2629443CCanadaC
CA2629455CCanadaC
CY1116156T1CyprusT1
US9573964B2United States of AmericaB2
US2017112846A1United States of AmericaA1
US10517876B2United States of AmericaB2
US2020071339A1United States of AmericaA1
BRPI0618552B1BrazilB1
BRPI0618552B8This recordBrazilB8
US11135227B2United States of AmericaB2
US2022241291A1United States of AmericaA1